These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

904 related items for PubMed ID: 19741150

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor.
    Foster KA, Regan HK, Danziger AP, Detwiler T, Kwon N, Rickert K, Lynch JJ, Regan CP.
    Neurosci Res; 2009 Jan; 63(1):10-6. PubMed ID: 18951929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroprotective properties of the non-peptidyl radical scavenger IAC in rats following transient focal cerebral ischemia.
    Nurmi A, Miettinen TK, Puoliväli J, Pussinen R, Soleti A, Bagate K, Riccardino F, Grundy RI, Yrjänheikki J, Canistro D, Paolini M.
    Brain Res; 2008 May 01; 1207():174-81. PubMed ID: 18374313
    [Abstract] [Full Text] [Related]

  • 6. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury.
    Lennmyr F, Ericsson A, Gerwins P, Akterin S, Ahlström H, Terént A.
    Acta Neurol Scand; 2004 Sep 01; 110(3):175-9. PubMed ID: 15285775
    [Abstract] [Full Text] [Related]

  • 7. Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
    Allahtavakoli M, Moloudi R, Arababadi MK, Shamsizadeh A, Javanmardi K.
    Brain Res; 2009 May 19; 1271():121-7. PubMed ID: 19332033
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
    Hasegawa Y, Morioka M, Hasegawa S, Matsumoto J, Kawano T, Kai Y, Yano S, Fukunaga K, Kuratsu J.
    J Pharmacol Exp Ther; 2006 May 19; 317(2):875-81. PubMed ID: 16461588
    [Abstract] [Full Text] [Related]

  • 11. Buyang Huanwu Decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains.
    Cai G, Liu B, Liu W, Tan X, Rong J, Chen X, Tong L, Shen J.
    J Ethnopharmacol; 2007 Sep 05; 113(2):292-9. PubMed ID: 17692486
    [Abstract] [Full Text] [Related]

  • 12. VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly.
    Kaya D, Gürsoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T.
    J Cereb Blood Flow Metab; 2005 Sep 05; 25(9):1111-8. PubMed ID: 15829918
    [Abstract] [Full Text] [Related]

  • 13. The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats.
    Koyama J, Miyake S, Sasayama T, Chiba Y, Kondoh T, Kohmura E.
    Kobe J Med Sci; 2010 Aug 19; 56(1):E1-11. PubMed ID: 21063140
    [Abstract] [Full Text] [Related]

  • 14. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
    Golas JM, Lucas J, Etienne C, Golas J, Discafani C, Sridharan L, Boghaert E, Arndt K, Ye F, Boschelli DH, Li F, Titsch C, Huselton C, Chaudhary I, Boschelli F.
    Cancer Res; 2005 Jun 15; 65(12):5358-64. PubMed ID: 15958584
    [Abstract] [Full Text] [Related]

  • 15. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP, Xu QQ, Zhang Q, Zhang WP, Zhang LH, Wei EQ.
    Neurosci Lett; 2005 Oct 14; 387(1):5-10. PubMed ID: 16054296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
    Ikeda Y, Hokamura K, Kawai T, Ishiyama J, Ishikawa K, Anraku T, Uno T, Umemura K.
    Brain Res; 2005 Oct 26; 1060(1-2):73-80. PubMed ID: 16202986
    [Abstract] [Full Text] [Related]

  • 19. Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke model.
    Regan C, Shepherd C, Strack A, Weinberg D, Nargund R, Ye Z, Pollard P, Fong T, Reynolds I, Lynch J.
    Pharmacology; 2009 Oct 26; 83(1):38-44. PubMed ID: 19052481
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.